Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cara Therapeutics, Inc. | Director | Common Stock | 198K | $149K | $0.75 | Jun 4, 2024 | Direct |
Acumen Pharmaceuticals, Inc. | Director | Common Stock | 12.8K | $14.1K | $1.10 | Jun 4, 2025 | Direct |
Cara Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 195K | Jun 4, 2024 | Direct | ||
Acumen Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 19.5K | Jun 4, 2025 | Direct |